http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2121039-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate | 1992-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_491a7b417ef37e26d3428d975cd12dd0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a00ed6e2d410742635567495715ec29a |
| publicationDate | 1993-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2121039-A1 |
| titleOfInvention | Use of misoprostol for the treatment of allergy |
| abstract | Methods for treating and preventing allergic reactions with misoprostol are disclosed. Aerosol, tablet, topical, and parenteral forms of misoprostol as a pharmaceutical agent are also described. Respiratory and cutaneous allergic reactions particularly in late-phase allergic reactions, to dust mites, food, occupational allergens, pollen, drugs, animal dander and chemicals may be treated with the described misoprostol-containing agents. Urticaria, contact dermatitis, atopic dermatitis, asthma, allergic rhinitis and anaphylaxis are conditions which may be treated according to the presently disclosed methods and pharmaceutical agents with misoprostol. |
| priorityDate | 1991-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.